# Assessment of CA 19-9 in Patients' With Thyroid Malignancies

> **NCT05124938** · — · UNKNOWN · sponsor: **Sohag University** · enrollment: 120 (estimated)

## Conditions studied

- Thyroid Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Laboratory investigations for control: a-Complete blood count. b-Liver function test. c-kidney function test. d-thyroid-stimulating hormone,T3 and T4. e-Assessment of levels of CA19-9.

## Key facts

- **NCT ID:** NCT05124938
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2021-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05124938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05124938, "Assessment of CA 19-9 in Patients' With Thyroid Malignancies". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT05124938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*